Clinical observation of recombinant human erythropoietin in treatment of preoperative anemia in patients with gastric cancer

Pharmaceutical Care and Research

Volumn 6, Issue 5, 2006, Pages 355-357

  Zhou, Li Xin ^a   Wu, Wei Xin ^a   Li, Ming ^a   Yu, Wei Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Anemia; Blood transfusion, allogeneic; Erythropoietin, recombinant; Intraoperative period; Stomach neoplasma

Indexed keywords

FERRIC CITRATE; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PATIENT SAFETY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; TREATMENT OUTCOME;

EID: 33750805031     PISSN: 16712838     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. DUNNE J R, MALONE D, TRACY J K, et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery [J]. J Surg Res, 2002, 102 (2):237-244.
2. CAZZOLA M, MERCURIALI F, BRUGNARA C. Use of recombinant human erythropoietin outside the setting of uremia [J]. Blood,1997,89(12): 4248-4267.
3. HEISS M M. The value of blood transfusion in tumor surgery. Experiences from randomized trials [J]. Zentralbl Chir,2000,125(10):842-846.
4. HYUNG W J, NOH S H, SHIN D W, et al. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer [J]. Ann Surg Oncol,2002,9(1):5-12.
5. GOODNOUGH L T, BRECHER M E, KANTER M H, et al. Transfusion medicine. First of two parts - blood transfusion [J]. N Engl J Med, 1999,340(11):438-447.
6. Chinese source. 2000:713,791,800.
7. KOSMADAKIS N, MESSARIS E, MARIS A, et al. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer. Prospective randomized double-blind study [J]. Ann Surg, 2003, 237(3): 417-421.